Category: News & Events

Comparison of the “Late Catch-Up” Phenomenon Between BuMA Supreme and XIENCE Stents Through Serial Optical Coherence Tomography at 1–2 Month and 2 Year Follow-Ups: A Multicenter Study

Comparison of the “Late Catch-Up” Phenomenon Between BuMA Supreme and XIENCE StentsAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at comparing the “late catch-up” phenomenon between the BuMA Supreme bioresorbable polymer sirolimus-eluting stent and the XIENCE stent through serial optical coherence tomography (OCT) at within 2 months and 2 year follow-ups.

A total of 49 of 75 patients from the PIONEER-II study were enrolled in a 2 year OCT follow-up study; 44 patients with 50 lesions were included in the statistical analysis. The primary endpoints were neointimal thickness and late luminal loss (LLL) after stent implantation. (more…)

Loading

The Evolving Role of Transcatheter Tricuspid Valve Edge-to-Edge Repair in Tricuspid Regurgitation

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Growing evidence indicates that severe tricuspid regurgitation (TR) is independently associated with adverse clinical outcomes. The prognostic benefit of isolated TR surgery remains unclear, and medical therapy for decompensated right heart failure alone cannot delay disease progression. TR assessment and management have substantially evolved in recent years. Currently, minimally invasive catheter-based techniques have emerged as a feasible and effective option for TR treatment in high-risk surgical patients.

(more…)

Loading

Medical Economic Consequences, Predictors, and Outcomes of Immediate Atrial Fibrillation Recurrence after Radiofrequency Ablation

Atrial Fibrillation Recurrence

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Immediate recurrence (Im-Recurr), a type of atrial fibrillation (AF) recurrence occurring during the blanking period after radiofrequency catheter ablation (RFCA), has received little attention. Therefore, this study was aimed at exploring the clinical significance of Im-Recurr in patients with AF after RFCA.

(more…)

Loading

Causal Associations Between the Gut Microbiome and Aortic Aneurysm: A Mendelian Randomization Study

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Observational studies have indicated an association between the gut microbiota and the occurrence and progression of aortic aneurysm (AA). However, the causal relationship between the gut microbiota and AA and its subtypes remains unclear. This study used Mendelian randomization (MR) to gain new insights into the relationship between the gut microbiota and AA, including AA subtypes.

(more…)

Loading

Advances in MicroRNA-Mediated Regulation of Cardiomyocyte Injury After Coronary Microembolization

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Coronary microembolization (CME) occurs in patients with acute coronary syndrome and is caused primarily by atherosclerotic plaque rupture associated with surgery. CME can lead to arrhythmias, decreased coronary blood flow reserve, and cardiac systolic dysfunction. The clinical efficacy of conventional coronary artery dilation, antiplatelet agents, and direct thrombus aspiration after CME is not satisfactory.

(more…)

Loading

Transcatheter “Sandwich” Valve-in-Valve Implantation Technique for Pure Aortic Regurgitation: Operation Skills and Single Center Experience

“Sandwich” Valve-in-Valve Implantation TechniqueAnnouncing a new article publication for Cardiovascular Innovations and Applications journal.  No commercial “on-label” transfemoral transcatheter aortic valve replacement (TAVR) device for aortic regurgitation (AR) is available in most countries. TAVR for AR with an “off-label” self-expanding device has shown acceptable procedural success but it elevated rates of early mortality and other complications. (more…)

Loading